Eyewire News: The Podcast
92 episodes — Page 2 of 2
B+L Launches New Scleral Lenses Technology
May 21, 20253 min
B+L Receives Approval in Europe for LuxLife IOL
May 14, 20255 min
Ophthalmic Leaders Launch SightLine Meeting
May 7, 20259 min
Breaking News from the ASCRS Meeting in Los Angeles
Apr 30, 202514 min
FDA Issues CRL to Regeneron for Eylea HD Extended Dosing
Apr 23, 20254 min
Orasis Launches Presbyopia Eye Drop Qlosi
Apr 16, 20259 min
Utilizing AI to Provide DR Screening to Underserved Communities
Apr 9, 202517 min
Alcon Launches PanOptix Pro in US
Apr 2, 20256 min
Alcon Announces Plans to Acquire Lensar
Mar 26, 20255 min
FDA Expands Product Label for Iluvien
Mar 19, 20254 min
FDA Approves First Treatment for MacTel
Mar 12, 20258 min
Haag-Streit Launches METIS 900 Microscope
Mar 5, 20254 min
New Myopia Software on Pentacam AXL
Feb 26, 20254 min
Alcon Voyager DSLT Fully Launched in US
Feb 19, 20256 min
AAO Opposes NIH Research Funding Proposal
Feb 12, 20255 min
FDA Approves Genentech's Susvimo Ocular Implant for DME
Feb 5, 20255 min
Norlase Launches First Pattern Scanning LIO
Jan 29, 20256 min
Zeiss MEL 90 Approved by FDA
Jan 22, 20255 min
Special Report – Increasing Access to Care Through the Cure Blindness Project
Jan 15, 20259 min
Glaukos Submits NDA for Epi-On CLX Candidate
Jan 8, 20255 min
2024 Year in Review — Part 2
Jan 1, 202512 min
2024 Year in Review — Part 1
Dec 25, 202411 min
B+L Bolsters Glaucoma Offerings with Elios Acquisition
Dec 18, 20244 min
Phase 3 Results for Novel Sedation Tablet
Dec 11, 20244 min
Phakic IOL for Presbyopia Approved in Europe
Dec 4, 20244 min
Special Report: OWL Celebrates 20th Anniversary
Nov 27, 20247 min
Lumithera CEO Discusses FDA Authorization for Veleda for Dry AMD
Nov 20, 202410 min
Ophthalmic Executives Provide Company Updates (Part 2 of 2)
Nov 13, 202415 min
Ophthalmic Executives Provide Company Updates (Part 1 of 2)
Nov 6, 202431 min
Posterior Segment Company Updates
Oct 30, 20247 min
Breaking News From the AAO Meeting in Chicago
Oct 23, 202413 min
B+L Receives FDA Approval for enVista Envy IOL
Oct 16, 20244 min
Aldeyra Resubmits NDA for DED Drug Reproxalap
Oct 9, 20244 min
Water-Free Ciclosporin-Based Eye Drop for DED Approved in Europe
Oct 2, 20244 min
Two Partnerships Formed to Advance Glaucoma Treatments
Sep 25, 20244 min
Breaking News From the ESCRS Congress in Barcelona (Part 2 of 2)
Sep 18, 202410 min
Breaking News From the ESCRS Congress in Barcelona (Part 1 of 2)
Sep 11, 202412 min
Weekly Headlines: First Therapy for Acanthamoeba Keratitis Approved in Europe
Sep 4, 20244 min
Weekly Headlines: Rayner Unveils First AI-Designed Spiral IOL
Aug 28, 20244 min
Weekly Headlines: Gene Therapies for IRDs Receive FDA Rare Pediatric Disease Designations
Aug 21, 20244 min
Weekly Headlines: Aldeyra Reports New Phase 3 Data for DED Drug Candidate Reproxalap
Aug 14, 20245 min
Weekly Headlines: Two Phase 3 Trials for Dry and Wet AMD Drug Candidates Begin
Aug 7, 20246 min